Speaker Profile
Ph.D., Professor/CSO, UMass/Organicin Scientifi
Biography
Dr. Margaret Riley is a Professor of Biology at the University of Massachusetts, where she is renowned for her pioneering work in the field of antimicrobial therapies. Her research focuses on bacteriocinsnaturally occurring antimicrobial peptides produced by bacteriawhich hold significant potential as alternative therapies to traditional antibiotics, particularly in the fight against antibiotic-resistant pathogens. Dr. Rileys interdisciplinary approach combines microbiology, evolutionary biology, and clinical applications, making her a leading figure in the development of novel strategies to manage infectious diseases. Her work has been instrumental in advancing our understanding of how alternative antimicrobials can be harnessed to target specific pathogens while minimizing harm to beneficial microbiota
Session Abstract – PMWC 2025 Silicon Valley
Track Chairs:
Charles Chiu, UCSF
- PMWC 2025 Award Ceremony
Pioneer Honoree: Julie Louise Gerberding, FNIH
- Keynote: From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics
- Julie Louise Gerberding, FNIH
- Harnessing Emerging Diagnostic Technologies in Primary and Critical Care (PANEL)
Chair: Mylynda Massart, UPMC
- Christopher Woods, Duke
- Helen Chu, U of Washington
- Yvonne Maldonado, Stanford
- Rose Lee, NIH - New Viral and Microbiome Associations with Cancer
Chair: Charles Chiu, UCSF
- Nancy Joseph, UCSF
- Melody Smith, Stanford
- Metagenomics and Partnerships: Monitoring Infectious Disease Threats
- Duncan MacCannell
- Adi V. Gundlapalli, CDC
- Mindy Nye, LabCorp - Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management (PANEL)
- Victor Nizet, UCSD
- Brad Spellberg, LA General Medical Center
- Nevan Krogan, UCSF
- Margaret Riley, University of Massachusetts
